Qube Research & Technologies (QRT)’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Buy
560,824
+106,033
+23% +$2.98M 0.01% 1029
2026
Q1
$13M Buy
454,791
+164,251
+57% +$5.61M 0.01% 1125
2025
Q4
$11.5M Buy
290,540
+195,811
+207% +$7.18M 0.01% 1258
2025
Q3
$3.34M Buy
94,729
+63,531
+204% +$2.19M ﹤0.01% 1981
2025
Q2
$1.02M Sell
31,198
-19,993
-39% -$650K ﹤0.01% 2447
2025
Q1
$1.65M Buy
+51,191
New +$1.9M ﹤0.01% 2039
2024
Q3
Sell
-22,019
Closed -$501K 3298
2024
Q2
$501K Sell
22,019
-192,213
-90% -$4.44M ﹤0.01% 2147
2024
Q1
$6.52M Sell
214,232
-11,188
-5% -$375K 0.01% 1066
2023
Q4
$8.05M Buy
225,420
+124,223
+123% +$4.62M 0.02% 823
2023
Q3
$4.43M Buy
101,197
+19,356
+24% +$944K 0.01% 991
2023
Q2
$4.04M Buy
81,841
+36,420
+80% +$1.68M 0.01% 763
2023
Q1
$1.88M Buy
+45,421
New +$1.88M 0.01% 1033
2022
Q2
Sell
-21,414
Closed -$1.41M 2479
2022
Q1
$1.41M Buy
21,414
+13,337
+165% +$864K 0.01% 992
2021
Q4
$562K Buy
+8,077
New +$587K ﹤0.01% 1505
2020
Q3
Sell
-27,019
Closed -$1.22M 1671
2020
Q2
$1.22M Buy
+27,019
New +$1.18M 0.02% 802

Other funds holding ATRC

Qube Research & Technologies (QRT)'s ATRC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its AtriCure (ATRC) stake by 23% in Q2 2026, buying an estimated $2.98M and bringing the position to 560,824 shares worth $15.7M. The position accounts for 0.01% of the portfolio, ranked #1029.

Qube Research & Technologies (QRT) first reported a position in ATRC in Q2 2020 and has held it in 15 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Qube Research & Technologies (QRT) held 560,824 shares of AtriCure worth $15.7M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 106,033 AtriCure shares in Q2 2026, an estimated $2.98M.
  • AtriCure made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1029 holding.
  • Qube Research & Technologies (QRT) first reported a position in AtriCure in Q2 2020 and has held it in 15 quarters since.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.